chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; vomiting; This spontaneous case was reported by a pharmacist and describes the occurrence of DIARRHOEA (diarrhea) and VOMITING (vomiting) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Aug-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Aug-2021, the patient experienced DIARRHOEA (diarrhea) and VOMITING (vomiting). At the time of the report, DIARRHOEA (diarrhea) and VOMITING (vomiting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant drug was not reported. Treatment medications were not reported.
This spontaneous report was received from a licensed practical nurse and refers to a 67 year old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was inadvertently vaccinated with a first dose of GARDASIL 9 (dose, route of administration, lot# and expiration date were not reported). There were no adverse symptoms reported.
Headaches started 12/2017 migraines per Neurology, but also MRI with hyperintense lesion on T2 flair, stable over 6 months.
PATIENT STATES AFTER SHE RECEIVED THE VACCINE, SHE EXPERIENCED A LITTLE BIT OF ITCHYNESS, REDNESS, AND SWELLING FROM INJECTION SITE TO ALMOST ELBOW AREA THE VERY NEXT DAY INCLUDING FEELING NAUSEOUS AND CHILL/FEVER. THEN PATIENT CALLED TO NOTIFY DOCTOR AND WAS INSTRUCTED TO COME TO PHARMACY TO LET US KNOW ABOUT IT. PATIENT ALSO STATED USING A HOMEOPATHIC MEDICATION TO HELP RELIEVE HER SYMPTOMS.
This is an instance of breakthrough COVID-19 after which death occurred.   The individual was vaccinated with the Pfizer product on 01/14/2021, 02/04/2021, and 10/13/2021. They presented to Emergency Dept on 02/05/2022 with primary compliant of shortness of breath. They tested positive for COVID-19 and were admitted to hospital same day. A second COVID-19 test on 02/06/2022 was also positive. While hospitalized, they were hypoxic and found to have MSSA Pneumonia. They required intubation and mechanical ventilation. They were also found to have an E. coli urinary tract infection. They were discharged to hospice care at a nursing home facility on 02/21/2022.  A COVID-19 test on 02/21/2022 was negative. They died on 03/17/2022.
ITCHY RASH ON CHEST, NIPPLES AND GRADUALLY SPREAD TO LEFT LEG; LEFT SIDED HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced left sided headache. On 11-APR-2021, the subject experienced itchy rash on chest, nipples and gradually spread to left leg. On 13-APR-2021, treatment medications included: diphenhydramine hydrochloride, and prednisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from left sided headache, and had not recovered from itchy rash on chest, nipples and gradually spread to left leg. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not needed as per standard procedure since case is assessed as non-serious.
Pain in left upper arm began on evening of 11-20-15. Continues to have pain in arm and shoulder joint. Occasionally, pain radiates to elbow. Taking ibuprofen. Recommend physician evaluation.
Warm to touch area of redness 5 in x 4.5 in. Areas of swelling 4 in x 4 in. Prescribed BENADRYL 12.5 ml/5 cc
She had flu like symptoms; She had some arm pain; she is really sick; This is a spontaneous report from contactable consumer. This consumer (mother) reported that, a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot Number: not reported, Expiry Date: Unknown), dose 1 via an unspecified route of administration on an unspecified date as a DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The reporter said that, on an unspecified date she (patient) is really sick, she had flu like symptoms, and she had some arm pain. Reporter stated, "I am calling about my daughter, she had the Pfizer vaccine, and she is really sick. She has had both doses and the 1st time she had flu like symptoms. Afterwards she had some arm pain but then it seemed to go away and then she asked the pharmacist before she the 2nd one if she should get it or if that was normal. He said yeah that was normal, no problem and then she got the 2nd one and she was been so ill ever since. She had been in emergency room like 5 times. So, we need to find somebody that knows the side effects and what we supposed to do about it." Reporter stated, "Do you have the (website name) that they mentioned on the thing?" Reporter further stated, "That is not what they said on the message. It was something about the (website name)." Reporter said I already reported it, I just want to get information on what I am supposed to do to help her." Outcome of all the events were unknown.  The lot number for the vaccine [BNT162B2] was not provided and will be requested during follow up.
according to the mom pt arm was edematous & red from elbow to shoulder p/1st dose;pt c/o extreme pain in arm where hep b was given;swelling lasted over 3 days;
Shingrix only adjuvant; Received only the adjuvant; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 56-year-old female patient who received Herpes zoster (Shingrix) (batch number 4NY45, expiry date 15th September 2023) for prophylaxis.   On 16th September 2022, the patient received Shingrix. On 16th September 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 20-Sept-2022 Reporter's comment: The reporter consented to follow-up. Additional supportive information: The patient received only the adjuvant AS01B of shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
sick; pretty significant abdominal cramping; diaphoretic; clammy; diarrhea; chills; nausea; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), ABDOMINAL PAIN (pretty significant abdominal cramping), HYPERHIDROSIS (diaphoretic), COLD SWEAT (clammy) and DIARRHOEA (diarrhea) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (sick), ABDOMINAL PAIN (pretty significant abdominal cramping), HYPERHIDROSIS (diaphoretic), COLD SWEAT (clammy), DIARRHOEA (diarrhea), CHILLS (chills), NAUSEA (nausea) and VOMITING (vomiting). At the time of the report, ILLNESS (sick), ABDOMINAL PAIN (pretty significant abdominal cramping), HYPERHIDROSIS (diaphoretic), COLD SWEAT (clammy), DIARRHOEA (diarrhea), CHILLS (chills), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Patient had no temperature and blood pressure was fine.
Anxiety/panic attack after- issues catching breath, hyperventilating,  fast HR rate but WNL- Forgot his inhaler at home. Had a family member pick him up and take him home for the day- advised him if symptoms persist, immediately to the ER
Client reported an onset of chest pain the morning after receiving the 1st COVID vaccine Pfizer. The client described the chest pain as dull and intermittent. The client stated the chest pain resolved after about 1 hour. The client stated she has previously experienced similar "chest pain when I gets sick." The client did not take any medications for the chest pain and did not seek any medical care regarding the chest pain. The client denied any s/s of anaphylaxis following the 1st COVID vaccine Pfizer.  The client has no chronic conditions. She currently takes oral contraceptive Drospirenona. The client has a history of anaphylactic reactions to eggs. Vitals obtained at 2:47 PM were as follows: HR 80, BP 128/80, and O2 99%. RN submitted a medical consult via text message. Approval to proceed with the 2nd COVID vaccine Pfizer was obtained by Vaccine Operations. RN educated the client on s/s of anaphylaxis, pericarditis, and myocarditis. The client voiced understanding of this. RN also educated the client on when to seek EMS services and when to follow up with a primary care doctor, v-safe, and recommended a 30 minute waiting period. The client voiced understanding of this. The client received the 2nd COVID vaccine Pfizer at 3:26 PM. The client tolerated the vaccine well and did not report any symptoms to the EMT's during the observation period.
Arm of injection broke out in a fine rash - itchy migraine headache a couple hours after injection lasted about 12 hours.
A report was received from a health care professional on 09Dec02 concerning a 11 year old male vaccinee who experienced bilateral pain and weakness at the triceps which began 2 weeks after administration of Fluvirin in the week beginning 28Oct02. Two weeks after receiving 0.5ml Fluvirin IM in the week beginning on the 28Oct02 the vaccinee experienced bilateral pain and weakness at the triceps. Fluvirin was administered on the right deltoid. At the time of reporting it was reported that the pain and weakness had resolved 100%. There was insufficient information to determine the reporters causality assessment. Cross reference with: PJP200200836.
This case was reported by a other health professional via sales rep and described the occurrence of vaccination failure in a 18-month-old female patient who received PEDIARIX. Co-suspect products included PEDIARIX, PEDIARIX and INFANRIX. On an unknown date, the patient received the 1st dose of PEDIARIX, the 2nd dose of PEDIARIX, the 3rd dose of PEDIARIX and the 1st dose of INFANRIX. On an unknown date, an unknown time after receiving PEDIARIX, PEDIARIX, PEDIARIX and INFANRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and pertussis were unknown. It was unknown if the reporter considered the vaccination failure and pertussis to be related to PEDIARIX, PEDIARIX, PEDIARIX and INFANRIX. Additional details were received as follows: The age at vaccination was not reported. The GlaxoSmithKline representative learned of a confirmed case of pertussis, which was reported to the Department of Health. This case was considered as suspected vaccination failure, since the details regarding confirmed laboratory tests for pertussis and the time to onset for pertussis were not provided. No further information was provided by the representative.
spasm in the left hand to the point he cannot bend his third left finger for 3-6months, every time he gets a shot.
Regular Pain; erythematous blotch on injection site; This case was reported by a physician via sales rep and described the occurrence of pain in a 18-year-old female patient who received Men B NVS (Bexsero) (batch number ABX794AZ, expiry date unknown) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Bexsero .5 ml. On 3rd August 2019, less than 6 months after receiving Bexsero, the patient experienced pain. In August 2019, the patient experienced injection site erythema. On an unknown date, the outcome of the pain and injection site erythema were unknown.   The reporter considered the pain and injection site erythema to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported but the patient could be 17 or 18 years old. On 3rd of August 2019, the patient had regular pain following her dose then erythematous blotch on injection site appeared on arm, 7 cm in size it was related to product. The reported batch ABS794A2 did not exist and was updated to ABX794AZ
Patient called to inform us that : he developed an itchy rash/ blisters within 3 days after the shot around the abdominal area - from one side to the other; the rash is still remaining after more than a week passed. The rash is also above the naval area lower chest region; Appearance: small red blisters 1/16th to 1/8th of an inch.
Patient stated he was not feeling good, he had numbness in the legs and hands, felt hot and weak/weird, itching and had a rash on his neck. No need for epi-pen. Called 911 as patients requested.
In 2014 I  experienced an adverse event following the influenza vaccine . It caused me to have neurological problems, along with breathing and cardiac issues. My condition was exacerbated after receiving my second dose of Pfizer vaccine. My neurological and cardiac issues have returned. I am currently seeing  a Cardiologist but they have not provided a diagnosis as of yet however I am getting tested for Pericarditis.
Patient was accidentally administered an undiluted dose of pfizer vaccine, which would be about twice the intended strength. Poison control was called and patient's family was informed. She was asymptomatic.
Body aches, chills, fatigue, arm soreness and redness at injection site. Symptoms improved after 24 hours.
Information has been received from a registered nurse concerning a 75 year old patient who on 07-FEB-2012 was vaccinated with a dose of ZOSTAVAX (Merck) (dose and route not reported) (lot number 671139/1265AA). On 20-APR-2012 the patient developed mild vesicular shingles rash on back of her neck, left upper chest, and upper arm. VALTREX and prednisone were given for the treatment. At the time of the report the patient's outcome was unknown. The patient sought unspecified medical attention. Follow up information has been received from a physician concerning the 75 year old female with no known drug allergy and illness at time of vaccination who on 07-FEB-2012 was vaccinated with a 0.7 ml dose of ZOSTAVAX (Merck) in right deltoid. Concomitant therapy included Tdap. On 20-APR-2012 the patient experienced zoster outbreak, vesicular on left back of her neck, left upper chest near clavicle and upper arm. The distribution of lesion was on left T1-T2. The maximum temperature was 98 C. The quantity of the pain was 4. There was no other systemic symptom. No direct fluorescent antibody was done. No specimen collected for PCR. No photo was taken. Subsequently, the patient recovered from the adverse events. No further information is available.
Tested positive for Covid 2 days prior to admission. Brought in by EMS due to unresponsive behavior as well as seizure like activity. On arrival patient was unresponsive but not intubated. She was intubated by the ER and become hypotensive. She was started on vasopressors and critical care was consulted for admission. She had progressive and worsening shock unresponsive to fluid or vasopressors. Per family she had been having fever since Tuesday and had been co,mplaining that her joints hurt. She didn't sleep last night and so her husband was letting her sleep in until around 11am this morning when she became rigid with some shaking. He called EMS who loaded her int he ambulance to bring her to the ER when she had a
Pt recvd 1st dose of Hep B vax in AUG 1991 & w/in 24 hrs following vax pt devel urticaria on face; no further details were provided;
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 21-NOV-2017, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N019923 and expiration date 28-APR-2019) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709:
Headache, Rash, Diarrhea, NauseaVomiting, Pain/Redness @ injection site Narrative:
pt developed a fever up to 103.9 on day 8 after vaccination. She also developed a macular papular rash over entire body with associated mild conjunctivitis.
This spontaneous report as received from a registered nurse via a company representative refers to a currently 22 year old female patient. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (injection, lot # K001504, expiry date 28-MAR-2015, dose and route were not provided).. On an unknown date the patient experienced cellulitis after receiving PNEUMOVAX 23. The patient sought medical attention by office visit on an unspecified date. The outcome of the event was not provided. Additional information has been requested.
Developed rigors and temp up to 104.6  over few hours post vaccination.  significant malaise, headache and muscle aches. Fever lasted up to 36 hours, malaise and body aches x72 hours. Symptoms completely resolved over few days.
Lost hearing in left ear.   I'm not sure if it is due to the vaccine but I felt I should report
Vaccines administered 6/1/11. Also treated for otitis externa at same visit. Onset of dizziness 6/2/11, persisting at least 3 days. Normal ENT, CV, neuro exams on 6/4/11 with normal orthostatic vs.
Persistent sore throat, right side, not inside esophagus, tender/sore when swallow and when pressed, lymph node area  Tylenol little effect
Dad brought pt in with redness and swelling at injection site. Advised dad to apply warm compress and give TYLENOL for arm pain and to come back or call for worsening symptoms.
Patient had fever to a maximum of 105 F.  Controlled with Tylenol, Advil, and cold baths.
BP: 118/62 PMH: Diabetes (on Vyctoza and metformin), took both Meds this Morning. Ate breakfast at 10 AM. Felt dizzy 15 minutes post vaccination while walking. Ambulate to healthcare. No true vertigo. No nausea or vomiting. No diaphoresis. No further symptoms. Discharge at 11:41AM
Palpating feeling in the left neck part/ Pumping in the neck vein; This spontaneous case was reported by a patient and describes the occurrence of PALPITATIONS (Palpating feeling in the left neck part/ Pumping in the neck vein) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Patient has no known allergies to food, medications or any products. Patient did not receive any other vaccine 1 month prior to getting the Moderna COVID-19 Vaccine.  Concurrent medical conditions included Diabetes (Start date was about 10 years ago and vaccine has no effect on his medical condition.).   On 17-Jun-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Jun-2022, the patient experienced PALPITATIONS (Palpating feeling in the left neck part/ Pumping in the neck vein). At the time of the report, PALPITATIONS (Palpating feeling in the left neck part/ Pumping in the neck vein) had not resolved.            Concomitant drugs were not reported.  The patient had pumping in the neck vein after receiving vaccine on 17-Jun-2022 around 11pm. The patient had this events for the first time and that the events had worsened. Patient did not seek medical care.  Treatment medications were not provided.   This case was linked to MOD-2022-592313 (Patient Link).